Effect of Active Exercise on Nutritional and Inflammatory Status, Muscle Metabolism and Cardiovascular Events in Maintenance Haemodialysis Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Renal Dialysis
- Sponsor
- Yunfeng Xia
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Mid-upper arm circumference of the non-internal fistula side（AC）
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
The goal of this clinical trial is to discuss the effects of physical activity on nutrition, inflammation, muscle metabolism, and the occurrence of cardiovascular and cerebrovascular events in patients with maintenance haemodialysis. The main question it aims to answer is: can exercise improve nutritional and inflammatory status, enhance muscle strength, and reduce the incidence of cardiovascular and cerebrovascular events in patients with maintenance haemodialysis.
Researchers will compared active exercise group to conventional treatment group to see the impact of exercise on maintenance haemodialysis patients.
Participants will:
Choose low-intensity aerobic exercise workouts such as walking (no less than 8,000 steps per day) or jogging, swimming, Tai Chi, etc., according to their individual conditions, for no less than 30 minutes at a time, at least 3 times per week, and the intensity of the exercise should be based on an RPE score of 12 to 16.
Detailed Description
RPE: Rating of Perceived Exertion. RPE scores of 12 to 16 indicate the need for increased respiratory rate and depth during exercise, the ability to engage in conversational exchanges, light sweating, and a feeling of slight fatigue without reaching a state of exhaustion.
Investigators
Yunfeng Xia
Doctor
First Affiliated Hospital of Chongqing Medical University
Eligibility Criteria
Inclusion Criteria
- •MHD more than 3 months, 3 times per week, 3-4h each time;
- •Urea clearance index (Kt/V) \>1.2;
- •Stable condition, no serious infection, tumour and cardiovascular disease;
- •Willing to join the study and sign the informed consent form.
Exclusion Criteria
- •Combined with serious heart and lung disease: such as repeated heart failure, severe arrhythmia, unstable angina pectoris, severe pericardial effusion, severe heart valve disease, hypertrophic cardiomyopathy, aortic coarctation, severe emphysema, pulmonary heart disease, severe pulmonary hypertension (average pressure of the pulmonary artery \> 55mmHg), etc.;
- •Combined with chronic joints, muscles, or vascular disease can not be or is not suitable for regular exercise, such as cerebrovascular disease; combined chronic joint, muscle or vascular disease can not or are not suitable for regular exercise, such as cerebrovascular disease sequelae, serious lower limb joint damage, severe myopathy, deep vein thrombosis, etc.;
- •unwilling to cooperate with the movement of people
Outcomes
Primary Outcomes
Mid-upper arm circumference of the non-internal fistula side（AC）
Time Frame: Baseline and half year, 1 year
Measure the circumference of the non-internal fistula at the midpoint of the upper arm using a soft tape measure, in centimetres
upper arm muscle circumference of the non-internal fistula side（AMC）
Time Frame: Baseline and half year, 1 year
AMC（cm）= AC(cm) - 3.14 x TSF（cm）
grip strength
Time Frame: Baseline and half year, 1 year
Using a grip strength meter, with the patient seated and gripping the handle firmly with the palm of the non-internal fistulae side, measure twice and record the maximum grip strength value
triceps skin-fold thickness of the non-internal fistula side（TSF）
Time Frame: Baseline and half year, 1 year
Measurement of the skinfold at the midpoint of the upper arm on the non-internal fistula side by using a skinfold thickness gauge, in centimetres
Incidence of cardiovascular and cerebrovascular events
Time Frame: 1 year
Cardiovascular events include: heart failure episodes, sustained arrhythmias, myocardial infarction, and cerebrovascular events include: cerebral haemorrhage, cerebral infarction, transient ischaemic attack.
calf circumference
Time Frame: Baseline and half year, 1 year
Measure the calf circumference using a soft tape measure, in centimetres
Secondary Outcomes
- albumin(Baseline and half year, 1 year)
- c-reactive protein(Baseline and half year, 1 year)
- haemoglobin(Baseline and half year, 1 year)
- blood lipids(Baseline and half year, 1 year)
- prealbumin(Baseline and half year, 1 year)